Sivashankar Y, Chen Z
Front Epidemiol. 2024; 3:1067492.
PMID: 38455921
PMC: 10911007.
DOI: 10.3389/fepid.2023.1067492.
Sanchez-Recio R, Parrilla-Huertas J, Asensio-Martinez A, Valdivieso-Pardos S, Zuniga-Anton M, Cerdan-Bernad M
Front Public Health. 2023; 11:1257459.
PMID: 37886053
PMC: 10598373.
DOI: 10.3389/fpubh.2023.1257459.
Remesan A, Chandra Sekaran V, Jaihind Jothikaran T, Ashok L
Int J Environ Res Public Health. 2023; 20(19).
PMID: 37835104
PMC: 10572374.
DOI: 10.3390/ijerph20196834.
Qaderi K, Yazdkhasti M, Zangeneh S, Behbahani B, Kalhor M, Shamsabadi A
Sex Med. 2023; 11(2):qfad005.
PMID: 36970584
PMC: 10037164.
DOI: 10.1093/sexmed/qfad005.
Dogan F, Ozturk T
Forensic Sci Med Pathol. 2022; 19(2):169-174.
PMID: 36520378
PMC: 9753859.
DOI: 10.1007/s12024-022-00565-3.
Symptoms of mental illness among university student-athletes during the second wave of the COVID-19 pandemic lockdown in Canada.
Boudreault V, Labossiere S, Gauthier V, Brassard S, Couture S, Dionne F
Front Sports Act Living. 2022; 4:1017376.
PMID: 36339640
PMC: 9627313.
DOI: 10.3389/fspor.2022.1017376.
Family focused interventions that address parental domestic violence and abuse, mental ill-health, and substance misuse in combination: A systematic review.
Allen K, Melendez-Torres G, Ford T, Bonell C, Finning K, Fredlund M
PLoS One. 2022; 17(7):e0270894.
PMID: 35905105
PMC: 9337671.
DOI: 10.1371/journal.pone.0270894.
Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.
Kosobuski L, Hawn A, France K, Chen N, LaPlante C, Palombi L
J Am Pharm Assoc (2003). 2022; 62(5):1555-1563.e2.
PMID: 35428578
PMC: 8933963.
DOI: 10.1016/j.japh.2022.03.014.
Client perspectives on the accessibility and quality of substance use treatment during the COVID-19 pandemic.
Hubach R, ONeil A, Ernst C, Stowe M, Hickey M, Remondino M
Drug Alcohol Depend Rep. 2022; 1:100002.
PMID: 35156104
PMC: 8606257.
DOI: 10.1016/j.dadr.2021.100002.
How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
Nguyen T, Hoang G, Nguyen D, Nguyen A, Luong N, Laureillard D
Harm Reduct J. 2022; 19(1):6.
PMID: 35090482
PMC: 8799429.
DOI: 10.1186/s12954-021-00586-1.
Opioids in COVID-19: Two Sides of a Coin.
Palamim C, Boschiero M, Faria A, Valencise F, Marson F
Front Pharmacol. 2022; 12:758637.
PMID: 35069193
PMC: 8770909.
DOI: 10.3389/fphar.2021.758637.
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic.
Chong W, Acar Z, West M, Wong F
Cannabis Cannabinoid Res. 2022; 7(5):591-602.
PMID: 34981958
PMC: 9587770.
DOI: 10.1089/can.2021.0054.
Cross-Sectional Retrospective Assessments versus Longitudinal Prospective Assessments of Substance Use Change among Young Adults during COVID-19: Magnitude and Correlates of Discordant Findings.
Romm K, Patterson B, Arem H, Price O, Wang Y, Berg C
Subst Use Misuse. 2021; 57(3):484-489.
PMID: 34889710
PMC: 9099360.
DOI: 10.1080/10826084.2021.2012696.
The Value of Mechanistic Experiments to Target the Shared Neural Circuitry of Parenting and Addiction: The Potential for Video Feedback Interventions.
Barrett A, Mudiam K, Fisher P
Front Psychol. 2021; 12:703948.
PMID: 34671289
PMC: 8520908.
DOI: 10.3389/fpsyg.2021.703948.
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic.
Farhoudian A, Radfar S, Mohaddes Ardabili H, Rafei P, Ebrahimi M, Zonoozi A
Front Psychiatry. 2021; 12:646206.
PMID: 34421664
PMC: 8377291.
DOI: 10.3389/fpsyt.2021.646206.
Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.
Henderson R, McInnes A, Mackey L, Bruised Head M, Crowshoe L, Hann J
BMC Public Health. 2021; 21(1):1471.
PMID: 34320954
PMC: 8318046.
DOI: 10.1186/s12889-021-11495-0.
Predictors of negative psychosocial and health behavior impact of COVID-19 among young adults.
Romm K, Patterson B, Wysota C, Wang Y, Berg C
Health Educ Res. 2021; 36(4):385-397.
PMID: 34196369
PMC: 8344829.
DOI: 10.1093/her/cyab026.
The uptake and effectiveness of online cognitive behaviour therapy for symptoms of anxiety and depression during COVID-19.
Mahoney A, Li I, Haskelberg H, Millard M, Newby J
J Affect Disord. 2021; 292:197-203.
PMID: 34126311
PMC: 8177308.
DOI: 10.1016/j.jad.2021.05.116.
Changes in young adult substance use during COVID-19 as a function of ACEs, depression, prior substance use and resilience.
Romm K, Patterson B, Crawford N, Posner H, West C, Wedding D
Subst Abus. 2021; 43(1):212-221.
PMID: 34086537
PMC: 10920401.
DOI: 10.1080/08897077.2021.1930629.
Perceived impacts of the COVID-19 pandemic on cannabis-using emerging adults.
Bonar E, Chapman L, McAfee J, Goldstick J, Bauermeister J, Carter P
Transl Behav Med. 2021; 11(7):1299-1309.
PMID: 33904925
PMC: 8135484.
DOI: 10.1093/tbm/ibab025.
